Q&As from the EMA Webinar for Industry on Integration of EudraGMDP and OMS
Recommendation

14/15 October 2026
Vienna, Austria
Quality Oversight of Pharmaceutical Contract Manufacturing Organisations
At the beginning of October, we reported on important changes for entries in the EudraGMDP Database.
To inform about the new developments, the EMA had organized a webinar for industry on the integration of EudraGMDP and OMS. The webinar covered the following topics:
- Integration of EudraGMDP and OMS – implications for industry users;
- OMS services and activities;
- OMS change request process;
- customer service (EMA Service Desk)
- data quality management.
The EMA has now published a document entitled Questions and answers from the webinar for industry on integration of EudraGMDP and OMS.
The 13-page PDF document contains 87 questions raised during that webinar and the corresponding answers.
The slides shown during the webinar and the recording of the event were already published on the EMA website in October.
Related GMP News
23.09.2026FDA Inspection as GMP Evidence? Swissmedic Opens Up a New Option
23.09.2026New: Coordination of GMP Inspections for Centrally Authorised Products
16.09.2026How GMP Non-Compliance can stop a Marketing Authorisation Application
10.09.2026FDA Warning Letter: Inadequate Warehouse Controls and Lot Traceability
09.09.2026Specified Microorganisms and More - FDA Warning Letter


